Virtual Medicinal Product (VMP) - Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection vials Start Date 25-10-2022 End Date
Previous Name Previous Name Eptacog alfa (activated) 100,000unit powder and solvent for solution for injection vials Start Date 15-09-2008 End Date 24-10-2022
Abbreviated Name Abbreviated Name Eptacog alfa (activated) 2mg (100,000unit) inj vials Start Date 25-10-2022
Previous Abbreviated Name Eptacog alfa (activated) 100,000unit inj vials Previous Start Date 01-05-2009 Previous End Date 24-10-2022

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
B02BD08
BNF Codes
  • BNF code 02110000
SNOMED Codes
Code Start Date End Date
13895111000001102 15-09-2008

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Eptacog alfa activated Based on Ingredient Substance 2 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial